Europe Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023

List of Tables

The Europe Theranostics Market would witness market growth of 14.8% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $338.8 million by 2030. The UK market is exhibiting a CAGR of 13.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 15.7% during (2023 - 2030).

Theranostic agents, such as radiopharmaceuticals and targeted therapies, deliver therapeutic payloads directly to cancer cells while sparing healthy tissues, enhancing treatment efficacy, and minimizing side effects. Imaging techniques such as echocardiography, cardiac MRI, and computed tomography angiography (CTA) enable visualization of cardiac anatomy, function, and blood flow, aiding in diagnosing coronary artery disease, myocardial infarction, and heart failure.

Biomarker-based assays, including troponin and B-type natriuretic peptide (BNP), provide prognostic information and risk stratification for cardiovascular events. Theranostic strategies help identify high-risk patients for adverse cardiovascular outcomes, enabling personalized treatment plans and interventions to improve patient outcomes. Additionally, these also have applications in neurology for the diagnosis and management of neurological disorders such as Alzheimer's disease, Parkinson's disease, and stroke.

As per the Eurostat, the high incidence of cardiovascular diseases (CVDs) in Europe drives the demand for advanced diagnostic tools and techniques for early detection, risk assessment, and disease monitoring. The standardized death rate for cerebrovascular diseases in 2020 in Bulgaria (which had the highest rate among the EU Member States) was 8.4 times higher than in France. Therefore, the growing prevalence of cardiovascular disease in the region propels the market's growth.

Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Bayer AG
GE HealthCare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cardinal Health, Inc.
Canon, Inc.
Clarity Pharmaceuticals Ltd
Koninklijke Philips N.V.
Thermo Fisher Scientific, Inc.
Telix Pharmaceuticals Limited
ABX advanced biochemical compounds GmbH

Europe Theranostics Market Report Segmentation

By End User

Hospitals & Cancer Care Centers
Theranostics Centers
Research & Academic Centers

By Product

Radiopharmaceuticals
Diagnostic Imaging
IVD/Biomarker Screening
Software & Services

By Application

Prostate Cancer
Bone Metastasis
Other Cancers
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Europe Theranostics Market, by End User
- 1.4.2Europe Theranostics Market, by Product
- 1.4.3Europe Theranostics Market, by Application
- 1.4.4Europe Theranostics Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Europe Theranostics Market by End User

4.1Europe Hospitals & Cancer Care Centers Market by Country
4.2Europe Theranostics Centers Market by Country
4.3Europe Research & Academic Centers Market by Country

Chapter 5.Europe Theranostics Market by Product

5.1Europe Radiopharmaceuticals Market by Country
5.2Europe Diagnostic Imaging Market by Country
5.3Europe IVD/Biomarker Screening Market by Country
5.4Europe Software & Services Market by Country

Chapter 6.Europe Theranostics Market by Application

6.1Europe Prostate Cancer Market by Country
6.2Europe Bone Metastasis Market by Country
6.3Europe Other Cancers Market by Country
6.4Europe Others Market by Country

Chapter 7.Europe Theranostics Market by Country

7.1Germany Theranostics Market
- 7.1.1Germany Theranostics Market by End User
- 7.1.2Germany Theranostics Market by Product
- 7.1.3Germany Theranostics Market by Application
7.2UK Theranostics Market
- 7.2.1UK Theranostics Market by End User
- 7.2.2UK Theranostics Market by Product
- 7.2.3UK Theranostics Market by Application
7.3France Theranostics Market
- 7.3.1France Theranostics Market by End User
- 7.3.2France Theranostics Market by Product
- 7.3.3France Theranostics Market by Application
7.4Russia Theranostics Market
- 7.4.1Russia Theranostics Market by End User
- 7.4.2Russia Theranostics Market by Product
- 7.4.3Russia Theranostics Market by Application
7.5Spain Theranostics Market
- 7.5.1Spain Theranostics Market by End User
- 7.5.2Spain Theranostics Market by Product
- 7.5.3Spain Theranostics Market by Application
7.6Italy Theranostics Market
- 7.6.1Italy Theranostics Market by End User
- 7.6.2Italy Theranostics Market by Product
- 7.6.3Italy Theranostics Market by Application
7.7Rest of Europe Theranostics Market
- 7.7.1Rest of Europe Theranostics Market by End User
- 7.7.2Rest of Europe Theranostics Market by Product
- 7.7.3Rest of Europe Theranostics Market by Application

Chapter 8.Company Profiles

8.1Bayer AG
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5Recent strategies and developments:
  - 8.1.5.1Acquisition and Mergers:
- 8.1.6SWOT Analysis
8.2GE HealthCare Technologies, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expenses
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Partnerships, Collaborations, and Agreements:
- 8.2.6SWOT Analysis
8.3Siemens Healthineers AG (Siemens AG)
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Product Launches and Product Expansions:
- 8.3.6SWOT Analysis
8.4Cardinal Health, Inc.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4SWOT Analysis
8.5Canon, Inc.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
8.6Clarity Pharmaceuticals Ltd
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Research & Development Expenses
- 8.6.4SWOT Analysis
8.7Koninklijke Philips N.V.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Thermo Fisher Scientific, Inc.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expenses
- 8.8.5SWOT Analysis
8.9Telix Pharmaceuticals Limited
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5SWOT Analysis
8.10.ABX advanced biochemical compounds GmbH
- 8.10.1Company Overview
- 8.10.2SWOT Analysis

LIST OF TABLES

TABLE 1Europe Theranostics Market, 2019 - 2022, USD Million
TABLE 2Europe Theranostics Market, 2023 - 2030, USD Million
TABLE 3Europe Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4Europe Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5Europe Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 6Europe Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 7Europe Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 8Europe Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 9Europe Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 10Europe Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 11Europe Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12Europe Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13Europe Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 14Europe Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 15Europe Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 16Europe Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 17Europe IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 18Europe IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 19Europe Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 20Europe Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 21Europe Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22Europe Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23Europe Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24Europe Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25Europe Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 26Europe Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 27Europe Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 28Europe Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 29Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 30Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 31Europe Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 32Europe Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 33Germany Theranostics Market, 2019 - 2022, USD Million
TABLE 34Germany Theranostics Market, 2023 - 2030, USD Million
TABLE 35Germany Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36Germany Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37Germany Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 38Germany Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 39Germany Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 40Germany Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 41UK Theranostics Market, 2019 - 2022, USD Million
TABLE 42UK Theranostics Market, 2023 - 2030, USD Million
TABLE 43UK Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 44UK Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 45UK Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 46UK Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 47UK Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 48UK Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 49France Theranostics Market, 2019 - 2022, USD Million
TABLE 50France Theranostics Market, 2023 - 2030, USD Million
TABLE 51France Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 52France Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 53France Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 54France Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 55France Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 56France Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 57Russia Theranostics Market, 2019 - 2022, USD Million
TABLE 58Russia Theranostics Market, 2023 - 2030, USD Million
TABLE 59Russia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 60Russia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 61Russia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 62Russia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 63Russia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 64Russia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 65Spain Theranostics Market, 2019 - 2022, USD Million
TABLE 66Spain Theranostics Market, 2023 - 2030, USD Million
TABLE 67Spain Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 68Spain Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 69Spain Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 70Spain Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 71Spain Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 72Spain Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 73Italy Theranostics Market, 2019 - 2022, USD Million
TABLE 74Italy Theranostics Market, 2023 - 2030, USD Million
TABLE 75Italy Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 76Italy Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 77Italy Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 78Italy Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 79Italy Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 80Italy Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 81Rest of Europe Theranostics Market, 2019 - 2022, USD Million
TABLE 82Rest of Europe Theranostics Market, 2023 - 2030, USD Million
TABLE 83Rest of Europe Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 84Rest of Europe Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 85Rest of Europe Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 86Rest of Europe Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 87Rest of Europe Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 88Rest of Europe Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 89Key Information - Bayer AG
TABLE 90Key Information - GE HealthCare Technologies, Inc.
TABLE 91Key Information - Siemens Healthineers AG
TABLE 92key information - Cardinal Health, Inc.
TABLE 93Key Information - Canon, Inc.
TABLE 94Key Information - Clarity Pharmaceuticals Ltd
TABLE 95Key Information - Koninklijke Philips N.V.
TABLE 96Key Information - Thermo Fisher Scientific, Inc.
TABLE 97Key Information - Telix Pharmaceuticals Limited
TABLE 98Key Information - ABX advanced biochemical compounds GmbH

Europe Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents